[Federal Register Volume 60, Number 57 (Friday, March 24, 1995)]
[Notices]
[Page 15569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7311]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CRADA 95-002]
National Institute for Occupational Safety and Health;
Cooperative Research and Development Agreement
AGENCY: Centers for Disease Control and Prevention (CDC), Public Health
Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), National
Institute for Occupational Safety and Health (NIOSH), announces the
opportunity for potential collaborators to enter into a Cooperative
Research and Development Agreement (CRADA) to develop an inexpensive
aerosol generator to produce a solid sodium chloride aerosol with a CMD
between 0.06 and 0.11 m and a geometric standard deviation of
1.80 as measured by a differential mobility particle sizer.
It is anticipated that all inventions which may arise from this
CRADA will be jointly owned. The collaborator(s) with whom the CRADA is
made will have an option to negotiate an exclusive or nonexclusive
royalty-bearing license. The CRADA will be executed for a 2-year period
with the possibility of renewal for another 2-year period.
Because CRADAs are designed to facilitate the development of
scientific and technological knowledge into useful, marketable
products, a great deal of freedom is given to Federal agencies in
implementing collaborative research. The CDC may accept staff,
facilities, equipment, supplies, and money from the other participants
in a CRADA; CDC may provide staff, facilities, equipment, and supplies
to the project. There is a single restriction in this exchange: CDC MAY
NOT PROVIDE FUNDS to the other participants in a CRADA. This
opportunity is available until 30 days after publication of this
notice. Respondents may be provided a longer period of time to furnish
additional information if CDC finds this necessary.
FOR FURTHER INFORMATION CONTACT:
Technical
Ernest S. Moyer, Ph.D., Protective Equipment Section, Protective
Technology Branch, Division of Safety Research, NIOSH, CDC, ALOSH
Laboratories, 944 Chestnut Ridge Road, Mailstop P119 (Room 142),
Morgantown, West Virginia 26505, telephone (304) 285-5962, FAX (304)
285-6047.
Business
Theodore F. Schoenborn, Technology Transfer Coordinator, NIOSH,
CDC, 4676 Columbia Parkway, Mailstop R2, Cincinnati, Ohio 45226,
telephone, (513) 841-4305, FAX (513) 841-4500.
SUPPLEMENTARY INFORMATION: The inexpensive aerosol generator to produce
solid sodium chloride aerosol of the desired size and size distribution
will be used in determining filter penetration in accordance with
NIOSH-proposed new respirator regulations 42 CFR Part 84. The
generation system needs to be able to reproducibly produce sodium
chloride aerosol of known size (0.06-0.11 m CMD) and with a
standard deviation of 1.80. The aerosol's concentration
needs to be >10 mg/m3 and can be as high as 200 mg/m3. The
collaborator(s) and NIOSH will jointly perform the research aimed at
development of a commercially inexpensive system to achieve instrument
ruggedness and lowest possible cost per unit system. NIOSH will provide
technical expertise, consultation and guidance, system specifications,
verification of system integrity, and product evaluation and testing.
Since this CRADA involves the bringing together of diverse
technologies, a consortium of collaborators will be considered.
Technology derived under this CRADA will not be used for standards
setting.
Applicants will be judged according to the following criteria:
1. Adequacy and technical capabilities to develop the desired
technologies and product;
2. Ability to develop, produce, market, and support commercial
aerosol generation systems;
3. Evidence of technical credibility; and
4. Ability to complete the CRADA in a timely fashion.
This CRADA is proposed and implemented under the 1986 Federal
Technology Transfer Act: Pub. L. 99-502.
The responses must be made to: Theodore F. Schoenborn, Technology
Transfer Coordinator, National Institute for Occupational Safety and
Health, CDC, 4676 Columbia Parkway, Mailstop R2, Cincinnati, Ohio
45226.
Dated: March 17, 1995.
Linda Rosenstock,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention (CDC).
[FR Doc. 95-7311 Filed 3-23-95; 8:45 am]
BILLING CODE 4163-19-P
